These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38945526)

  • 41. Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.
    Jin Q; Lau ESH; Luk AO; Tam CHT; Ozaki R; Lim CKP; Wu H; Chow EYK; Kong APS; Lee HM; Fan B; Ng ACW; Jiang G; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Cheung EYN; Kam G; Lau IT; Li JK; Yeung VTF; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Yu W; Tsui SKW; Tomlinson B; Huang Y; Lan HY; Szeto CC; So WY; Jenkins AJ; Fung E; Muilwijk M; Blom MT; 't Hart LM; Chan JCN; Ma RCW;
    Diabetologia; 2024 May; 67(5):837-849. PubMed ID: 38413437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association Between Serum Homocysteine Levels and Severity of Diabetic Kidney Disease in 489 Patients with Type 2 Diabetes Mellitus: A Single-Center Study.
    Wu J; Liu D; Yang L; Liu J
    Med Sci Monit; 2022 Jun; 28():e936323. PubMed ID: 35684937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of -1082A>G Polymorphism in the Interleukin-10 Gene with Estimated Glomerular Filtration Rate in Type 2 Diabetes.
    Polina ER; da Silva Pereira BL; Crispim D; Sbruzzi RC; Canani LH; Dos Santos KG
    Kidney Blood Press Res; 2017; 42(6):1164-1174. PubMed ID: 29227971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetic Kidney Disease Without Albuminuria: A New Entity in Diabetic Nephropathy.
    Ahmadi N; Amouzegar A
    Iran J Kidney Dis; 2024 Jan; 1(1):1-8. PubMed ID: 38308545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A qualitative study documenting unmet needs in the management of diabetic kidney disease (DKD) in the primary care setting.
    Datar M; Ramakrishnan S; Montgomery E; Coca SG; Vassalotti JA; Goss T
    BMC Public Health; 2021 May; 21(1):930. PubMed ID: 34001084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The association between thyroid dysfunction (TD) and diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM).
    Zheng M; Wang D; Chen L; Chen MN; Wang W; Ye SD
    Int J Clin Pract; 2019 Sep; ():e13415. PubMed ID: 31508877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease.
    Zhang Q; Zhang Y; Zeng L; Chen G; Zhang L; Liu M; Sheng H; Hu X; Su J; Zhang D; Lu F; Liu X; Zhang L
    Front Pharmacol; 2021; 12():757508. PubMed ID: 34899312
    [No Abstract]   [Full Text] [Related]  

  • 48. Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
    Zhou Y; Qi C; Li S; Shao X; Mou S; Ni Z
    Cell Physiol Biochem; 2018; 51(3):1119-1133. PubMed ID: 30476916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
    Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
    Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Circulating Carbohydrate Antigen 19-9 Level with Type 2 Diabetic Kidney Disease in Chinese Adults: A Cross-Sectional Study.
    Yan P; Li J; Zhang Y; Dan X; Wu X; Zhang X; Yang Y; Chen X; Li S; Chen P; Wan Q; Xu Y
    Diabetes Metab Syndr Obes; 2024; 17():467-477. PubMed ID: 38312210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy.
    Bian X; Griffin TP; Zhu X; Islam MN; Conley SM; Eirin A; Tang H; O'Shea PM; Palmer AK; McCoy RG; Herrmann SM; Mehta RA; Woollard JR; Rule AD; Kirkland JL; Tchkonia T; Textor SC; Griffin MD; Lerman LO; Hickson LJ
    BMJ Open Diabetes Res Care; 2019; 7(1):e000720. PubMed ID: 31908790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urine clusterin/apolipoprotein J is linked to tubular damage and renal outcomes in patients with type 2 diabetes mellitus.
    Kim SS; Song SH; Kim JH; Jeon YK; Kim BH; Kang MC; Chun SW; Hong SH; Chung M; Kim YK; Kim IJ; Kim YB
    Clin Endocrinol (Oxf); 2017 Aug; 87(2):156-164. PubMed ID: 28434209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of urinary podocalyxin as an alternative marker for urinary albumin creatinine ratio in early stage of diabetic kidney disease in older patients.
    Xie Y; Jin D; Qiu H; Lin L; Sun S; Li D; Sha F; Zhou W; Jia M
    Nefrologia (Engl Ed); 2022; 42(6):664-670. PubMed ID: 36402681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heart and Kidney Outcomes With Ertugliflozin in People with Non-albuminuric Diabetic Kidney Disease: A
    Cherney DZI; Dagogo-Jack S; Cosentino F; Pratley RE; Frederich R; Maldonado M; Liu CC; Cannon CP
    Kidney Int Rep; 2022 Aug; 7(8):1782-1792. PubMed ID: 35967112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease.
    Liu JJ; Ghosh S; Kovalik JP; Ching J; Choi HW; Tavintharan S; Ong CN; Sum CF; Summers SA; Tai ES; Lim SC
    Kidney Int Rep; 2017 May; 2(3):470-480. PubMed ID: 29142974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The link between diabetic retinal and renal microvasculopathy is associated with dyslipidemia and upregulated circulating level of cytokines.
    Chen X; Zhang X; Gong Z; Yang Y; Zhang X; Wang Q; Wang Y; Xie R
    Front Public Health; 2022; 10():1040319. PubMed ID: 36733289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk.
    Scilletta S; Di Marco M; Miano N; Filippello A; Di Mauro S; Scamporrino A; Musmeci M; Coppolino G; Di Giacomo Barbagallo F; Bosco G; Scicali R; Piro S; Purrello F; Di Pino A
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated Urinary VEGF-A, Transferrin, and Angiotensinogen Levels in Normoalbuminuric Children and Adolescents with Type 1 Diabetes: Can They Be Early Markers of Diabetic Kidney Disease?
    Dağdeviren Çakır A; Saygılı SK; Canpolat N; Konukoğlu D; Turan H; Çalışkan S; Sever L; Ercan O; Evliyaoğlu O
    Horm Res Paediatr; 2021; 94(11-12):426-432. PubMed ID: 34915504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of traditional Chinese herbal medicine in patients with diabetic kidney disease: study protocol for a randomized controlled trial.
    Wang M; Wang Z; Zhou J; Sun W; Wang Y; Han M; Yang H; Liu WJ; Wang Y
    Trials; 2018 Jul; 19(1):389. PubMed ID: 30016983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.